Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To assess the anti-tumor efficacy of oral single agent PF-02341066 administered to patients with advanced NSCLC after failure of at least one line of chemotherapy and harbor a translocation or inversion event involving the ALK gene locus as measured by ORR; • To assess the safety and tolerability of oral PF-02341066.
Critère d'inclusion
- metastatic non-small cell lung cancer